52263-23-7

Usage

Uses

Due to the limited information available on (4-Oxocyclohexyl)acetic Acid, its specific applications are not well-documented. However, based on its chemical structure and properties as a carboxylic acid, it can be inferred that it may have potential uses in the following areas:
Used in Chemical Synthesis:
(4-Oxocyclohexyl)acetic Acid may be used as a building block or intermediate in the synthesis of more complex organic compounds, particularly those involving cyclohexane rings or ketone functional groups.
Used in Research and Development:
Due to its unique structure, (4-Oxocyclohexyl)acetic Acid may be used in research settings to study the properties and reactivity of carboxylic acids and their derivatives, as well as to explore potential applications in various fields.
Used in Pharmaceutical Industry:
Although not explicitly mentioned, the compound's potential acidic properties and ability to partake in esterification reactions could make it a candidate for use in the development of pharmaceutical compounds, where it could serve as a precursor or a functional group in drug molecules.

InChI:InChI=1/C8H12O3/c9-7-3-1-6(2-4-7)5-8(10)11/h6H,1-5H2,(H,10,11)

Upstream product

• 99799-09-4 2-(4-hydroxycyclohexyl)acetic acid 
• 66405-41-2 (4-oxo-cyclohexyl)-acetic acid methyl ester 
• 58012-34-3 ethyl 4-oxocyclohexaneacetate 
• 134136-04-2 (1,4-dioxa-spiro[4.5]-dec-8-yl)-acetic acid 

Downstream Products

• 66336-36-5 [4-Hydroxy-4-(4-methoxy-phenyl)-cyclohexyl]-acetic acid 
• 931424-52-1 N-(3-dimethylamino-3,4-dihydro-2H-benzo[b][1,4]dioxepin-3-ylmethyl)-2-(4-oxo-cyclohexyl)-acetamide 
• 928063-59-6 (4-Hydroxy-4-methyl-cyclohexyl)-acetic acid 
• 66336-55-8 (4'-Oxo-bicyclohexyliden-2'-en-4-yl)-acetic acid methyl ester 
• 66336-37-6 (4'-Oxo-bicyclohexyliden-2'-en-4-yl)-acetic acid 
• 68592-23-4 trans-(4-hydroxy-cyclohexyl)-acetic acid 
• 68592-22-3 cis-(4-hydroxy-cyclohexyl)-acetic acid 

Relevant academic research and scientific papers

Nitrogen-containing ring derivative regulator as well as preparation method and application thereof

The invention relates to a nitrogen-containing ring derivative regulator as well as a preparation method and an application thereof. In particular, the present invention relates to a compound represented by general formula (I), a preparation method thereof, a pharmaceutical composition containing the compound, and an application of the compound as a G-protein coupled receptor modulator in the treatment or prevention of central nervous system diseases and/or mental diseases.

Benzimidazole derivatives, their preparation and their application in medicine and pharmacology (by machine translation)

The invention relates to a new control or inhibit indocyanine 2, 3 - dioxygenase (IDO) activity of the benzimidazole derivatives, their preparation and their application in medicine and pharmacology. Specifically, the invention relates to a compound of general formula (I) compound of formula and its pharmaceutically acceptable salt, containing the compound or its pharmaceutically acceptable salt of the pharmaceutical composition, the use of the compound or its pharmaceutically acceptable salts for treating and/or preventing the relevance of the IDO-mediated disease, especially a tumor of the method and the compound or its pharmaceutically acceptable salts thereof. The invention also relates to the compound or its pharmaceutically acceptable salt or containing the compound or its pharmaceutically acceptable salts for the preparation of a pharmaceutical composition for treating and/or preventing the relevance of the IDO-mediated disease, in particular of the use of the drug in the tumor. Wherein the general formula (I) of each substituent is as defined in the specification. (by machine translation)

BENZOYL-PIPERIDINE DERIVATIVES AS DUAL MODULATORS OF THE 5-HT2A AND D3 RECEPTORS

The present invention relates to compounds of formula (I) wherein R1 and A are as defined in the specification as dual modulators of the serotonin 5-HT2a and dopamine D3 receptors, their manufacture, pharmaceutical compositions containing them and their use as medicaments. Compounds of general formula (I) have high affinity for the dopamine D3 and serotonin (5-Hydroxytryptamine; 5-HT) 5-HT2A receptors and are effective in the treatment of psychotic disorders, as well as other diseases such as depression and anxiety, drug dependence, dementias and memory impairment.

DUAL MODULATORS OF 5HT2A AND D3 RECEPTORS

The present invention relates to compounds of the formula (I) wherein R1, R2, X and n are as defined in the specification as dual modulators of the serotonin 5-HT2a and dopamine D3 receptors, their manufacture,

INHIBITORS OF SERINE PROTEASES FOR THE TREATMENT OF HCV INFECTIONS

The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof. These compounds inhibit serine protease, particularly the hepatitis C virus NS3-NS4A protease.

INHIBITORS OF SERINE PROTEASES

The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt or mixtures thereof that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3-NS4A protease.

SUBSTITUTED TETRAHYDROBENZOTHIAZOLES AS DOPAMINERGIC AGENTS

Substituted tetrahydrobenzothiazoles are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as dopamine agonists with selectivity for the presynaptic dopamine receptor and are useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.